Video | October 2, 2025

Patient centricity is top of mind across the drug development pipeline, particularly when it comes to ensuring the success of clinical trials. Many sponsors are pivoting to decentralized clinical trials that leverage electronic health records, wearable devices, and digital health technologies. As a result, trial teams are navigating higher and more diverse data volumes than ever before, and AI-enabled trial tools are emerging as powerful options for data management.

Naomi Wilson, Vice President of Clinical Data Management at PPD , the clinical research business of Thermo Fisher Scientific, recently spoke to why the clinical space is changing, and how Thermo Fisher Scientific’s Intelligent Clinical Suite, an AI-powered data management tool, was designed to accommodate these changes. Watch the full video to hear Wilson’s insights and explore how Intelligent Clinical Suite is helping teams ensure accuracy, precision, and speed.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

PPD Clinical Research Business of Thermo Fisher Scientific